Tauroursodeoxycholic acid

Drug Profile

Tauroursodeoxycholic acid

Alternative Names: Tauroursodeoxycholate sodium; UR 906

Latest Information Update: 12 Oct 2001

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Mitsubishi Pharma Corporation
  • Class Antivirals; Gallstone therapies; Hepatoprotectants
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Liver disorders

Most Recent Events

  • 12 Oct 2001 No-Development-Reported for Liver disorders in Japan (Injection)
  • 16 Nov 1999 Tokyo Tanabe has been acquired by Mitsubishi Chemical
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top